Lamivudine And Zidovudine Tablet
Product Images NDC 71335-1916

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lamivudine And Zidovudine (NDC 71335-1916). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lami (Lamizido Lamivudine)

FDA Label Image

Zido (Lamizido Zidovudine)

FDA Label Image

Label (Lbl713351916)

Label (Lbl713351916)
This appears to be a description of a medication package for Lamivudine and Zidovudine pills. Lamivudine is a white capsule with a strength of ML6, while Zidovudine comes in 150mg or 300mg tablet form. The packaging recommends keeping the pills in a light-resistant container at room temperature. There is an expiration date listed as "EXP MM/YY" and an NDC number provided as well. It is not clear what "Dachaged by Buyant Ranch Prcpach Bunbank, 04 91508" means.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.